National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

Found 26279 cases where Vaccine is PNC13

Case Details (Reverse Sorted by Appearance Date)

This is page 83 out of 1314

Result pages: prev   64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102   next


VAERS ID: 721101 (history)  
Form: Version 2.0  
Age: 0.0  
Gender: Male  
Location: Massachusetts  
Vaccinated:2016-10-10
Onset:2016-10-10
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) / SANOFI PASTEUR UT5897JA / 1 RL / IM
HEPA: HEP A (VAQTA) / MERCK & CO. INC. N008823 / 1 LL / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. N002337 / 1 LL / SC
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S31241 / 4 RL / IM

Administered by: Private       Purchased by: 0
Symptoms: Pyrexia
SMQs:, Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Cold SX; Afebrile
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Fever after immunisations. No swelling or irritation. Cold SX''s at time of visit.


VAERS ID: 720048 (history)  
Form: Version 2.0  
Age: 0.17  
Gender: Female  
Location: Foreign  
Vaccinated:2016-09-12
Onset:2016-09-15
   Days after vaccination:3
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS - / 2 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / 2 UN / UN
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 2 MO / PO

Administered by: Unknown       Purchased by: 0
Symptoms: Blood test normal, Gene mutation identification test, Metabolic function test normal, Myoclonic epilepsy, Urine analysis normal
SMQs:, Systemic lupus erythematosus (broad), Convulsions (narrow), Generalised convulsive seizures following immunisation (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Prophylaxis
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: AU0095075131710AUS001688

Write-up: Information was obtained on a request by the Company from the agency via a Public Case Detail concerning a 9 week old female patient. The patient''s medical history, drug allergies, concurrent conditions and concomitant therapies were not reported. On 12-SEP-2016, the patient was vaccinated with the second dose of ROTATEQ 1 unspecified oral dose, 1 time, for prophylaxis (lot number and expiration date were not provided). Other suspect therapies included INFANRIX HEXA 1 unspecified dose, 1 time (route, anatomical location, lot number and expiration date were not provided), and PREVENAR 13 1 unspecified dose, 1 time (route, anatomical location, lot number and expiration date were not provided) both for prophylaxis. On 15-SEP-2016, the patient experienced myoclonic seizures for 10 seconds at home. It was reported an emergency department visit which included observation abs "xl" in hospital. The patient did not have fever. There were the following laboratory diagnostics and studies performed: Blood tests, urine tests, metabolic tests, Magnetic Resonance Imaging (MRI) and nothing abnormal detected (NAD), and a MTHER gene testing with result pending. It was reported that the patient was treated with unspecified intravenous antibiotics and antivirals on unknown dates. At the time of reporting, the patient had recovered from myoclonus and the agency assessed the causal relationship between the suspect therapies and the event as possibly related. Upon internal review, the event of myoclonus was considered to be medically significant. The original reporting source was a healthcare professional.


VAERS ID: 720102 (history)  
Form: Version 2.0  
Age: 0.08  
Gender: Female  
Location: Foreign  
Vaccinated:2016-09-25
Onset:2016-09-25
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
6VAX-F: DTAP+IPV+HEPB+HIB (INFANRIX HEXA) / GLAXOSMITHKLINE BIOLOGICALS - / 1 UN / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / 1 UN / UN
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 1 MO / PO

Administered by: Other       Purchased by: 0
Symptoms: Continuous positive airway pressure, Hypopnoea, Respiratory arrest, Respiratory rate increased, Unresponsive to stimuli
SMQs:, Anaphylactic reaction (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Acute central respiratory depression (narrow), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hypotonic-hyporesponsive episode (broad), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? Yes
Previous Vaccinations:
Other Medications:
Current Illness: Prophylaxis
Preexisting Conditions: Medical History/Concurrent Conditions: Premature baby 33 to 36 weeks
Allergies:
Diagnostic Lab Data:
CDC Split Type: AU0095075131710AUS002102

Write-up: Information was obtained on a request by the Company from the agency (HA#404098) via a Public Case Detail regarding a 2 months old female patient. The patient was born pre-term 36/40 and was an inpatient at time of first dose of vaccines. On 25-SEP-2016, the patient was vaccinated with ROTATEQ dose 1, 1 DF orally (strength, lot # and expiry date were not reported) for prophylaxis. Other suspect therapies PREVENAR 13 dose 1, 1 DF (strength, lot # and expiry date were not reported) for prophylaxis and INFANRIX HEXA dose 1, 1 DF (strength, lot # and expiry date were not reported) for prophylaxis; all of which were administered on 25-SEP-2016. On the same date (reported as within minutes of the vaccination), the patient was unresponsive (Hyporesponsive to stimuli) and breathing rate was decreased (hypopnea). The patient was treated with continuous positive airway pressure (CPAP) for hypopnea and medical emergency team (MET) call was initiated. On 07-DEC-2016, the patient was vaccinated with ROTATEQ dose 2, 1 DF orally, lot# M002439, expiry date: 31-OCT-2017 for prophylaxis. Other suspect therapies PREVENAR 13 dose 2, 1 DF, batch #: N28762 (strength and expiry date were not reported) and INFANRIX HEXA dose 2, 1 DF, batch #: AA21CC631 (strength and expiry date were not reported) for prophylaxis were administered on 07-DEC-2016. It was unknown if the nurse was aware of the previous events post first dose of the vaccines (reported as post the 2 month vaccines). On 07-OCT-2016, the parents of the patient waited 15 minutes (reported as ?1S'' minutes) after vaccination and while they are in the car park preparing to leave, the patient became unresponsive (Hyporesponsive to stimuli) and stopped breathing (hypopnea). The patient''s parents immediately ran in to the emergency department (ED), where patient was kept under observation from 10:34 until 13:11 hours. The outcome of the events was reported as recovered. The reporter considered hypopnoea and hyporesponsive to stimuli to be possibly related to the suspect therapies. Upon internal review hypopnoea was considered to be medically significant. The events were serious due to hospitalization.


VAERS ID: 720132 (history)  
Form: Version 2.0  
Age: 0.5  
Gender: Female  
Location: Foreign  
Vaccinated:2017-08-28
Onset:2017-09-02
   Days after vaccination:5
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S06096 / 3 LL / IM

Administered by: Other       Purchased by: 0
Symptoms: Alanine aminotransferase, Albumin urine absent, Aspartate aminotransferase, Basophil count normal, Bilirubin urine, Blood alkaline phosphatase increased, Blood chloride normal, Blood count normal, Blood creatine phosphokinase normal, Blood potassium normal, Blood sodium decreased, Blood urea decreased, Blood urine absent, C-reactive protein increased, Cellulitis, Eosinophil count decreased, Erythema, Genital erythema, Glucose urine absent, Haematocrit normal, Haemoglobin normal, Inflammatory marker increased, Injection site erythema, Injection site oedema, Leukocytosis, Liver function test normal, Lymphocyte count decreased, Mean cell haemoglobin concentration, Mean cell haemoglobin decreased, Mean cell volume normal, Monocyte count decreased, Neutrophil count decreased, Nitrite urine absent, Platelet count, Pyrexia, Red blood cell count normal, Renal function test normal, Urine ketone body present, Urine output, Urobilinogen urine, Vaginal oedema, White blood cell count increased, White blood cells urine negative, pH urine normal
SMQs:, Liver related investigations, signs and symptoms (broad), Anaphylactic reaction (broad), Angioedema (broad), Haematopoietic leukopenia (narrow), Hyperglycaemia/new onset diabetes mellitus (narrow), Neuroleptic malignant syndrome (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Biliary system related investigations, signs and symptoms (broad), Extravasation events (injections, infusions and implants) (broad), Hyponatraemia/SIADH (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Chronic kidney disease (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 4 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: VIGANTOL
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Hypertension (Mother of her father (grandmother)); Thyroid disorder (Mother of her mother (grandmother)); Type II diabetes mellitus (Father of her father (grandfather))
Allergies:
Diagnostic Lab Data: Test Date: 201709; Test Name: Alanine aminotransferase; Result Unstructured Data: Test Result: 0.25, Test Result Unit: IU/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 20170909; Test Name: Albumin urine; Result Unstructured Data: Test Result: 0; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Albumin urine; Result Unstructured Data: Test Result: 0; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Aspartate aminotransferase; Result Unstructured Data: Test Result: 0.53; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 20170905; Test Name: Basophil count; Result Unstructured Data: Test Result: 0.000; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 20170907; Test Name: Basophil count; Result Unstructured Data: Test Result: 0.000; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 20170909; Test Name: Bilirubin urine; Result Unstructured Data: Test Result: 0; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Bilirubin urine; Result Unstructured Data: Test Result: 0; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Blood alkaline phosphatase; Result Unstructured Data: Test Result: 3.65; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Cl; Result Unstructured Data: Test Result: 102, Test Result Unit: mmol/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Chloride; Result Unstructured Data: Test Result: 107, Test Result Unit: mmol/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 20170905; Test Name: Creatine phosphokinase; Result Unstructured Data: Test Result: 72.4, Test Result Unit: mg/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 20170907; Test Name: Creatine phosphokinase; Result Unstructured Data: Test Result: 41.9, Test Result Unit: mg/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: K; Result Unstructured Data: Test Result: 4.7, Test Result Unit: mmol/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Sodium; Result Unstructured Data: Test Result: 133, Test Result Unit: mmol/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1 arb.u. U_nitrites (09Sep2017): 0 arb.u. U_Glucose (09Sep2017): 0 arb.u. U_acetone bodies (09Sep2017): 0 arb.u. U_albumin (09Sep2017): 0 arb.u. U_Urobilinogen (09Sep2017):0 arb.u. U_Bilirubin (09Sep2017): 0 arb.u U_Leukocyte (09Sep2017): 0 arb.u. U_Blood (09Sep2017): 0 arb.u; U_Erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017) 0 arb.u. U_erythrocyte (05Sep2017 - 07Sep2017): 0 arb.u. U_erythrocyte (09Sep2017): 0 arb.u. U_squamous epithelial (05Sep2017 - 07Sep2017): 0 arb.u. U_squamous epithelial (09Sep2017): 1 arb.u.; Test Date: 201709; Test Name: Urea; Result Unstructured Data: Test Result: 1.9, Test Result Unit: mmol/l; Comments: BMI (05Sep2017) 14.8 kg/m2 BSA (05Sep2017) 0.347 m2 pulse (05Sep2017) 128/minute chest circumference (05Sep2017): 40 cm head circumference (05Sep2017): 42 cm Objective findings (05Sep2017):psycho motor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo MCV (05Sep2017): 80.4 ft MCV (07Sep2017): 79.9 ft ALT (Sep2017) 0.25 ?kat/L AST (Sep2017) 0.53 ?kat/L qAST/ALT (Sep2017): 2.12 ALP (Sep2017): 3.65 ukat/l Urine Volume (Sep2017):1.020 kg/m*3 Urine ascorbic acid (Sep2017): 2 arb.u. U_nitrites (Sep2017): 0 arb.u. U_Glucose (Sep2017): 0 arb.u. U_acetone bodies (Sep2017): 2 arb.u. U_albumin (Sep2017): 0 arb.u. U_Urobilinogen (Sep2017): 0 arb .u. U_Bilirubin (Sep2017): 0 arb.u. U_Leukocyte (Sep2017): 1 arb.u. U_Blood (Sep2017): 0 arb.u. U_Erythrocyte (Sep2017): 0 arb.u. U_squamous epithelial (Sep2017): 0 arb.u. U_Volume (09Sep2017 ) 1.015 kg/m*3 U_ascorbic acid(09Sep2017): 1
CDC Split Type: CZPFIZERINC2017385833

Write-up: This is a spontaneous report from a contactable consumer (patient''s mother). A 6-month-old female patient received the 3rd dose of PREVENAR 13 (Lot: s06096 / exp. May2019), intramuscular on the left thigh, on 28Aug2017 at 11:45 a.m., at 0.5 ml single, for immunisation. Relevant medical was not reported. Concomitant medication included VIGANTOL one drop 1x/day (in the evening). No allergy. Previously she took two doses of pneumococcal 13-val conj vaccine, on 22Jun2017 (1st dose, lot S06096 - exp. May2019) and on 21Jul2017 (2nd dose, lot S62875 - exp. Apr2019) for immunization with no adverse effect. She also took as vaccination: ROTATEQ on 05Apr2017 (lot M043553 - exp. May2018) on 24May2017 (lot M043553 - exp. May2018) on 22Jun2017 (lot N000309 Sep2018) and HEXACIMA on 26Apr2017 (lotL0324) and on 21Jul2017 (lot M7531). At night from 02Sep2017 to 03Sep2017 fever was at 39 C and small pink spot on the injection site on the thigh that spread and subsequently the entire half got swelling and extended to the front. Pink spot on her left buttock occurred, the spot was getting bigger and redden during hours. In about 24 hours, the pink spot became a red oedema. The mother visited a physician office on 04Sep2017. It was recommended to use a cream and wrap it. Therapeutic measures also included treatment with NUROFEN and some ointment, but the ointment did not help. The body temperature decreased after PANADOL suppository, together with cold body wrap for temperature reduction. On 05Sep2017 fever was 38,5 - 39,5 C persist. The oedema extended to vagina. On 05Sep2017 the pediatrician recommended hospitalization: patient was hospitalized due to the events from 05Sep2017 to 09Sep2017. Diagnoses was Phlegmon of the left buttock, groin and labia majora on the left side. Final outcome of the events was recovering. The physician said that the patient was probably bitten by an insect. Patient''s mother disagree, as they have got windows nets: when patient was in the buggy, there was a net and before put her daughter into the buggy, she check the buggy. She thought that if something bit her daughter, the oedema would not extend for three days. The physician did not agree that the events were related to the vaccination. Discharge Report: Family history: The father and the Mother were healthy. Paternal grandmother had hypertension and paternal grandfather had Type 2 diabetes mellitus; maternal grandmother had thyreopathy. Patient had a healthy sister. Personal history: patient was vaccinated according to the vaccination schedule pneumococcal 13-val conj vaccine and rotavirus vaccine live reassort oral 5v. Psychomotor development normal. Until the report, the child has not been ill. The patient was referred by the GP for phlegmon of the left buttock extending to the genitals; the mother reported that on 02Sep2017, the patient developed fever - which persisted until the admission. On 02Sep2017, a small red spot on the buttocks, which gradually increased in size. The spot extended to the genitals. There was no cough, no runny nose, no vomiting, no diarrhoea, no loss of appetite; the patient was in pain. The GP initiated the patient on local therapy - RIVANOL and FUCIDIN ointment. On 04Sep2017 the CRP level was 25 mg/l. Objective findings on 05Sep2017: BMI 14.8 kg/m2 and BSA 0.347 m2, temperature 38.6C, pulse 128/minute, head circumference 42 cm, chest circumference 40 cm; psychomotor responses, hydration and perfusion normal. Consciousness normal. Large fontanelle was normal and not pulsating. Throat clear, tonsils and neck lymph nodes not enlarged, heart rate regular, no murmur, alveolar clear breathing, abdomen soft and palpable, no response to pain, peristalsis +/+. On the left buttock reddish induration extending across the left groin onto genitals. The entire left side of the genitals was indurated and red. Otherwise, the skin was without any dermatosis, only at the back of the neck intertrigo. Results of laboratory examinations done on 05Sep2017 11:36 a.m. and on 07Sep2017 at 11:06 a.m. showed respectively: White blood cell count (LE) 21.9x10*9/l and 14.1x10*9/l; Red blood cell count (ER) 4.11x10*12/l and 4.27x10*12/l; Haemoglobin (HB) 104 g/l and 106 g/l ; hematocrit (HCT) 0.330 and 0.341; Mean cell volume (MCV ) 80.4 fl and 79.9 fl ; Mean cell haemoglobin (MCH) 25.3 pg and 24.8 pg; Mean cell haemoglobin concentration (MCHC) 315 g/l and 311 g/l; Platelet (TR) 348 x10*9/l and 419 x10*9/l ; monocyte (MONO) 0.08 and 0.10; lymphocyte (LYMF) 0.41 and 0.47;eosinophil (EOSI) 0.01 and 0.14; Basophil (BASO) 0.000 and 0.000; segmental neutrophils (NSEG) 0.41 and 0.27; Neutrophil count (NTYC) 0.09 and 0.02; creatine phosphokinase (CRPK) 72.4 mg/l and 41.9 mg/l. On an unknown date in Sep2017 urea 1.9 mmol/l, Na 133 mmol/l, K: 4.7 mmol/l, Cl: 102 mmol/l and Cl kor 107 mmol/l; ALT: 0.25 ?kat/L; AST: 0.53 ?kat/L; qAST/ALT 2.12; ALP: 3.65 ukat/l; Urine chemically in Sep2017 showed Urine (U) Volume: 1.020 kg/m*3; U_ascorbic acid: 2 arb .u; U nitrites 0 arb.U; U_pH: 5.5; U Glucose: 0 arb.u.; U_acetone bodies: 2 arb.u.; U_albumin: 0 arb.u.; U_Urobilinogen: 0 arb .u.;U_Bilirubin: 0 arb.u. ;U_Leukocyte: 1 arb.u.; U_Blood: 0 arb.u; U_Erythrocyte: 0 arb.u. ; U_squamous epithelial 0 arb.u. Control urine on 09Sep2017 09:30 a.m: U_Volume 1.015 kg/m*3 U_ascorbic acid: 1 arb.u. U_nitrites: 0 arb.u. U_pH: 7.5 - U_Glucose: 0 arb.u. U_acetone bodies: 0 arb.u.; U_albumin: 0 arb.u. U_Urobilinogen: 0 arb.u. ; U_Bilirubin: 0 arb.u U_Leukocyte: 0 arb.u. U_Blood: 0 arb.u; U_Erythrocyte: 0 arb.u. U_squamous epithelial 0 arb.u. Therapy: AMOKSIKLAV i.v., NUROFEN, PARALEN, VIGANTOL and body wraps with RIVANOL. Course of hospitalization: The patient was referred to clinic by her GP due to phlegmon of the left buttock extending to the groin and genitals associated with fever. Laboratory showed leucocytosis, high CRP levels; blood count, ions, renal and liver function tests were normal, cyto-biochemistry of urine - contaminated due to phlegmon; control analysis was normal. At clinic, the patient was treated with parenteral antibiotics with amoxicillin / clavulanate, and local compresses with ethacridine lactate. The therapy leads to improvement of the condition, the fever subsided as well as the local lesion. Laboratory showed decreasing inflammatory markers. On discharge, there was a barely visible decolorized lesion on the left buttock, groin and the genitals are intact, therefore the patient was switched to the oral antibiotics and was discharged home with a following recommendation. The patient / caregiver was informed about the character of the condition, further therapy and procedures. Diagnoses was Phlegmon of the left buttock, groin and labia majora on the left side. Recommendation: Amoxicillin / clavulanate 312.5 mg/ 5 ml 3x daily 2 ml every 8 hours for 7 days, i.e. until 12Sep2017. On 12Sep2017, follow-up visit at the GP. Follow-up attempts are completed. No further information is expected. Follow-up (05Oct2017): New information received from the patient''s mother includes: vaccination details, vaccination history, clinical course, event details, new event, lab tests, physician comment, treatment, clinical course and discharge report.


VAERS ID: 720134 (history)  
Form: Version 2.0  
Age: 69.0  
Gender: Female  
Location: Foreign  
Vaccinated:2017-09-12
Onset:2017-09-12
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S05818 / UNK UN / IM

Administered by: Other       Purchased by: 0
Symptoms: Erysipelas, Erythema, Feeling hot, Pyrexia
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: METFOREM; BUDESONIDE; INCRUSE
Current Illness: Asthma; COPD; Diabetes
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: FIPFIZER INC2017433099

Write-up: This is a spontaneous report from a contactable physician received from the Medicines Agency. Regulatory authority report number FI-FIMEA-20171440. A 69-year-old female patient of an unspecified race/ethnicity received PREVENAR 13 (lot number S05818) intramuscular, on 12Sep2017, at single dose, for immunization. The patient''s medical history included ongoing diabetes, ongoing asthma, ongoing COPD. Concomitant medications included oral metformin HCl (METFOREM) prolonged-release tablets, for diabetes, budesonide (unknown trade name) inhalation powder via respiratory inhalation, 400 ug, daily, for asthma and umeclidinium bromide (INCRUSE) inhalation powder pre-dispensed via respiratory inhalation, for COPD. The patient experienced redness, warmth and fever from 12Sep2017, after the vaccination. Erysipelas was diagnosed on 15Sep2017 and had not yet resolved at the time of report. The event erysipelas was considered medically significant.


VAERS ID: 720136 (history)  
Form: Version 2.0  
Age:   
Gender: Male  
Location: Foreign  
Vaccinated:2017-01-12
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 15A801 / UNK MO / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / UNK UN / UN
UNK: VACCINE NOT SPECIFIED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK UN / UN

Administered by: Other       Purchased by: 0
Symptoms: Injection site haemorrhage, Injection site induration, Injection site mass, Scratch, Vaccination site pruritus
SMQs:, Haemorrhage terms (excl laboratory terms) (narrow), Accidents and injuries (narrow), Extravasation events (injections, infusions and implants) (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: GBPFIZER INC2017435810

Write-up: This is a spontaneous report from a consumer via the contactable Medicines and Healthcare Products Regulatory Agency (MHRA). Regulatory Authority report number: GB-MHRA-ADR 24188297. An infant male patient (currently 13-month-old) of unknown age at events onset and of unknown race/ethnicity received PREVENAR 13 at single dose, BEXSERO (lot 15A801) and diphtheria vaccine toxoid, hib vaccine, pertussis vaccine, polio vaccine inact, tetanus vaccine toxoid (DTPA IPV HIB VACCINE), all parenterally, on 12Jan2017, for routine childhood immunization. No relevant medical history or concomitant medications were provided. On an unknown date in 2017, 8 months before the report, the patient experienced vaccination site lump and vaccination site pruritus, described as hard lumps in thighs at the injection site in both legs from 16 weeks immunisations. Baby consistently scratched both thighs and has drawn blood. It was 8 months on and the events had not yet resolved. The reporter considered the events to be serious as they were medically important conditions. The MHRA considered the events to be serious for an unspecified reason. No follow-up attempts possible. No further information expected.


VAERS ID: 720138 (history)  
Form: Version 2.0  
Age:   
Gender: Male  
Location: Foreign  
Vaccinated:2017-07-01
Onset:2017-09-01
   Days after vaccination:62
Submitted: 0000-00-00
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / UNK UN / UN

Administered by: Other       Purchased by: 0
Symptoms: Pancreatic neoplasm, Splenectomy, Surgery, Tumour excision
SMQs:, Malignancy related therapeutic and diagnostic procedures (narrow), Non-haematological tumours of unspecified malignancy (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Diabetes
Allergies:
Diagnostic Lab Data:
CDC Split Type: PTPFIZER INC2017437887

Write-up: This is a spontaneous report from a contactable pharmacist. A male patient aged between 65 to 70 years old, of an unspecified ethnicity received a dose of the PREVENAR 13, unknown lot number, via an unspecified route of administration on Jul2017 at single dose for immunisation. Medical history included diabetes mellitus. The patient''s concomitant medications were not reported. On Sep2017, approximately 3 weeks before the date of the report, the patient was submitted to a surgery to remove a pancreas tumor. During surgery, the spleen was also removed. At the time of this report, the outcome of the event was unknown.; Sender''s Comments: Reported event of pancreas tumor requiring surgery is not related to the use of PREVENAR 13 but represents an intercurrent medical condition. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 721086 (history)  
Form: Version 1.0  
Age:   
Gender: Female  
Location: Foreign  
Vaccinated:2017-09-06
Onset:2017-09-09
   Days after vaccination:3
Submitted: 2017-10-13
   Days after onset:34
Entered: 2017-10-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (NO BRAND NAME) / SANOFI PASTEUR N1D90 / UNK UN / IM
MENB: MENINGOCOCCAL B (BEXSERO) / NOVARTIS VACCINES AND DIAGNOSTICS 163401 / UNK UN / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH R175082 / UNK UN / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AROLB686AA / UNK MO / PO

Administered by: Other       Purchased by: Other
Symptoms: Intestinal resection, Necrotising colitis
SMQs:, Pseudomembranous colitis (broad), Malignancy related therapeutic and diagnostic procedures (narrow), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Gastrointestinal obstruction (narrow), Gastrointestinal ulceration (narrow), Ischaemic colitis (narrow)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: DALIVIT; Sodium feredetate; Caffeine citrate; Sodium phosphate
Current Illness: Low birth weight baby; Patent ductus arteriosus, Small. Requiring high prior to acute deterioration.
Preexisting Conditions: Premature baby, Born 25+1. Continuous positive airway pressure, Reactive oxygen species.
Allergies:
Diagnostic Lab Data:
CDC Split Type: GB2017155795

Write-up: This case was reported by a other health professional via regulatory authority and described the occurrence of necrotizing enterocolitis in a female patient who received ROTARIX (batch number AROLB686AA, expiry date unknown). The patient''s past medical history included premature baby (Born 25+1.) and continuous positive airway pressure (Reactive oxygen species). Concurrent medical conditions included extremely low birth weight baby and patent ductus arteriosus (Small. Requiring high prior to acute deterioration.). Concomitant products included BEXSERO, DALIVIT, PREVENAR 13, PEDIACEL, sodium feredetate, caffeine citrate and phosphoric acid, Sodium Phosphate. On 6th September 2017, the patient received ROTARIX (oral) 1.5 ml. On 9th September 2017, 3 days after receiving ROTARIX, the patient experienced necrotizing enterocolitis (serious criteria hospitalization, GSK medically significant and life threatening). On an unknown date, the outcome of the necrotizing enterocolitis was recovering/resolving. It was unknown if the reporter considered the necrotizing enterocolitis to be related to ROTARIX. Additional information: The patient age at vaccination was not given. Initial information was received from Other health professional via regulatory authority on 10th October 2017. Preterm infant developed necrotizine enterocolitis (NEC) post vaccines. Required transfer to surgical unit and surgery: bowel resection 30cm and reanastomaosis. Now recovering.


VAERS ID: 719730 (history)  
Form: Version 2.0  
Age: 0.0  
Gender: Male  
Location: Nevada  
Vaccinated:2017-04-11
Onset:2017-04-11
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS - / 3 LG / SYR
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / 3 LG / SYR
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. - / 3 LG / SYR

Administered by: Private       Purchased by: 0
Symptoms: Abdominal pain upper, Dyspnoea, Vomiting projectile
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Gastrointestinal perforation, ulcer, haemorrhage, obstruction non-specific findings/procedures (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Nexium; Udo?s Choice Infant Probiotic
Current Illness: Chronic congestion; Coughing; Sneezing
Preexisting Conditions: Reflux and chronic congestion
Allergies: Unsure
Diagnostic Lab Data:
CDC Split Type:

Write-up: Stomach ache around 11pm and projectile vomiting multiple times around 3am. Heavy breathing.


VAERS ID: 719805 (history)  
Form: Version 2.0  
Age: 31.0  
Gender: Female  
Location: Unknown  
Vaccinated:2017-10-11
Onset:2017-10-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / UNK - / -

Administered by: Private       Purchased by: 0
Symptoms: Chest discomfort, Neck pain
SMQs:, Anaphylactic reaction (broad), Arthritis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Quasense
Current Illness: none
Preexisting Conditions: athletically induced asthma
Allergies: ceclore, sulfa, amoxicillin
Diagnostic Lab Data:
CDC Split Type:

Write-up: I received the vaccine on 10/11/17 around 9 am and at 7 am on 10/12/17 I woke with a tightness in my chest and a sore neck. Pain of 5/6 on scale of 1-10.


VAERS ID: 719811 (history)  
Form: Version 2.0  
Age: 63.0  
Gender: Female  
Location: Florida  
Vaccinated:2017-10-03
Onset:2017-10-10
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S39564 / 1 RA / IM

Administered by: Private       Purchased by: 0
Symptoms: Erythema, Pyrexia, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: HYPERLIDIPDEMIA, HYPERTHYROIDISM
Allergies: DARVON
Diagnostic Lab Data:
CDC Split Type:

Write-up: SWELLING, REDNESS, FEVER.


VAERS ID: 719838 (history)  
Form: Version 1.0  
Age: 80.0  
Gender: Female  
Location: Georgia  
Vaccinated:2017-10-06
Onset:2017-10-11
   Days after vaccination:5
Submitted: 2017-10-12
   Days after onset:1
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) / SANOFI PASTEUR UI875AB / 1 RA / UN
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S35324 / 1 LA / UN

Administered by: Other       Purchased by: Other
Symptoms: Pain in extremity, Peripheral swelling, Sensory loss
SMQs:, Cardiac failure (broad), Angioedema (broad), Peripheral neuropathy (narrow), Guillain-Barre syndrome (broad), Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: NK
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient returned to pharmacy on 10/12/17 stating on the evening of 10/11/17 she began to have pain in Left hand and swelling. Reports loss of feeling and pain today with visual swelling.


VAERS ID: 719845 (history)  
Form: Version 2.0  
Age: 1.0  
Gender: Male  
Location: Unknown  
Vaccinated:2017-09-29
Onset:2017-10-01
   Days after vaccination:2
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU4: INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS - / 1 LL / IM
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS - / 1 RL / IM
MMRV: MEASLES + MUMPS + RUBELLA + VARICELLA (PROQUAD) / MERCK & CO. INC. - / 1 RL / SC
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / 4 RL / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 1 LL / SC

Administered by: Private       Purchased by: 0
Symptoms: Injection site erythema, Injection site rash, Irritability, Poor quality sleep
SMQs:, Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Extravasation events (injections, infusions and implants) (broad), Hostility/aggression (broad), Depression (excl suicide and self injury) (broad), Hypersensitivity (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: No
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data:
CDC Split Type:

Write-up: He has not had any fevers. He has been more fussy than usual and has slept poorly every night since the shots. Last night the parents noticed red bumps on his left thigh. He is otherwise well.


VAERS ID: 719876 (history)  
Form: Version 2.0  
Age:   
Gender: Male  
Location: Unknown  
Vaccinated:2017-05-31
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / UNK UN / UN

Administered by: Unknown       Purchased by: 0
Symptoms: Cardiac disorder, Erythema, Inflammation, Pain in extremity
SMQs:, Anaphylactic reaction (broad), Hypersensitivity (broad), Tendinopathies and ligament disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asplenia
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2017435172

Write-up: This is a spontaneous report from a contactable nurse received via Pfizer company representative. A 62-year-old male patient of an unspecified ethnicity received PREVNAR 13, via an unspecified route of administration on 31May2017 at single dose for immunization. Medical history included asplenia. The patient''s concomitant medications were not reported. After vaccination patient experienced local inflammation and redness from his shoulder to his elbow as well as arm pain. Patient was still experiencing arm pain. Patient also experienced a cardiac event after vaccination. The outcome of event arm pain was not recovered, the outcome of the other events was unknown.


VAERS ID: 719905 (history)  
Form: Version 2.0  
Age: 74.0  
Gender: Male  
Location: Florida  
Vaccinated:2017-10-05
Onset:2017-10-12
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
FLU3: INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE) / SANOFI PASTEUR UI871AB / 1 LA / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S58702 / UNK RA / IM

Administered by: 0       Purchased by: 0
Symptoms: Erythema, Injection site bruising
SMQs:, Anaphylactic reaction (broad), Haemorrhage terms (excl laboratory terms) (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness: Unknown
Preexisting Conditions: Unknown
Allergies: NKDA
Diagnostic Lab Data: Unknown
CDC Split Type:

Write-up: Right arm had bruise where vaccine administered but concern was underneath had large red box that appeared to possibly be allergic reaction (PREVNAR).


VAERS ID: 719934 (history)  
Form: Version 2.0  
Age: 0.17  
Gender: Male  
Location: Michigan  
Vaccinated:2016-03-28
Onset:2016-03-28
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 RL / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 LL / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 RL / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 LL / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / 1 LL / IM

Administered by: Private       Purchased by: 0
Symptoms: Constipation, Diarrhoea, Muscle disorder, Screaming, Seizure
SMQs:, Rhabdomyolysis/myopathy (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Pseudomembranous colitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Generalised convulsive seizures following immunisation (narrow), Noninfectious diarrhoea (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: My ex and I share 50/50, I don''t medicate. He does.
Current Illness: No other known illnesses
Preexisting Conditions: He''s two months old.
Allergies: Not that I know of
Diagnostic Lab Data:
CDC Split Type:

Write-up: My grandson was force vaccinated against my daughter''s consent. My daughter has a severe learning disability and has authorized me to advocate on her behalf, so I''m helping her submit this report. We''ve observed seizures, muscle freezing, problems with constipation and diarrhea, and high pitched screaming starting spring of 2016. He was taken from her at birth and her now ex-husband, a convicted pedophile only allowed her to hold him twice. They were rescued from their predator, but father was able to manipulate 50/50 custody. Patient was force vaccinated without her consent on two additional dates in 2016. We will fill out separate forms for the other two dates.


VAERS ID: 719937 (history)  
Form: Version 2.0  
Age: 0.33  
Gender: Female  
Location: Maryland  
Vaccinated:2017-10-03
Onset:2017-10-10
   Days after vaccination:7
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS 914Y3 / 2 LL / IM
HIBV: HIB (ACTHIB) / SANOFI PASTEUR U1787AAA / 2 LL / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH R75851 / 2 RL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AA755 / 2 MO / PO

Administered by: Private       Purchased by: 0
Symptoms: Abdominal pain, Culture stool, Culture urine negative, Diarrhoea, Ear infection, Haematochezia, Malaise, Pyrexia, Vomiting
SMQs:, Acute pancreatitis (broad), Haemorrhage terms (excl laboratory terms) (narrow), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Retroperitoneal fibrosis (broad), Pseudomembranous colitis (broad), Gastrointestinal haemorrhage (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Noninfectious diarrhoea (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Zantac
Current Illness: Infant GERD
Preexisting Conditions: None
Allergies: NKDA
Diagnostic Lab Data: Urine Culture on 10/11/17 was Negative; Stool Culture on 10/12/17 Not yet resulted
CDC Split Type:

Write-up: Patient was brought to office on 10/11/2017 with abdominal pain, fever, diarrhea, and vomiting. Was diagnosed with a left ear infection and started on 10/11/17. Patients mother called office to be seen again on 10/12/17 and we had her go to lab to get a stool culture and then to come to the office. Patient was brought in with complaint from mother that infant still is not feeling better. Patient did have an ear infection, but when leaving the office patient changed diaper and it appeared to have blood in diaper. Patient was sent to Medical Center to be evaluated and treated.


VAERS ID: 719938 (history)  
Form: Version 2.0  
Age: 0.58  
Gender: Male  
Location: Michigan  
Vaccinated:2016-08-25
Onset:2016-03-28
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 RL / IM
HEP: HEP B (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 LL / IM
HIBV: HIB (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 RL / IM
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 1 LL / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH - / 1 LL / IM

Administered by: Private       Purchased by: 0
Symptoms: Constipation, Diarrhoea, Ear discomfort, Muscle disorder, Screaming, Seizure
SMQs:, Rhabdomyolysis/myopathy (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Pseudomembranous colitis (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Generalised convulsive seizures following immunisation (narrow), Noninfectious diarrhoea (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: My ex and I share 50/50, I don''t medicate. He does.
Current Illness: No other known illnesses
Preexisting Conditions: He''s two months old.
Allergies: Not that I know of
Diagnostic Lab Data:
CDC Split Type:

Write-up: My grandson was force vaccinated against my daughter''s consent. My daughter has a severe learning disability and has authorized me to advocate on her behalf, so I''m helping her submit this report. We''ve observed seizures, muscle freezing, problems with constipation and diarrhea, slapping his ears really hard, and high pitched screaming starting spring of 2016. He was taken from her at birth and her now ex-husband, a convicted pedophile only allowed her to hold him twice. They were rescued from their predator, but father was able to manipulate 50/50 custody. Pt was vaccinated without her consent.


VAERS ID: 719957 (history)  
Form: Version 2.0  
Age: 59.0  
Gender: Female  
Location: New York  
Vaccinated:2017-09-25
Onset:2017-09-26
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH S89564 / UNK LA / UN

Administered by: Private       Purchased by: 0
Symptoms: Injection site cellulitis, Injection site erythema, Injection site pain, Injection site swelling
SMQs:, Extravasation events (injections, infusions and implants) (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZERINC2017436092

Write-up: This is a spontaneous report from a contactable nurse. A 59-year-old female patient of an unspecified ethnicity received PREVNAR 13 (lot S89564, expiry date Sep2018) via an unspecified route of administration in the left deltoid on 25Sep2017 at 12:19 pm at 0.5 ml single for routine immunization. The patient medical history and concomitant medications were not reported. The patient experienced redness, swelling and pain at left upper arm since 26Sep2017 and she was diagnosed with cellulitis at left upper arm (vaccination site). The patient had previously received diphtheria, tetanus and acellular pertussis (TDAP) for routine immunization a few years before this report and she had experienced redness and swelling in the same arm. Reaction after pneumococcal 13-val conj vac (dipht crm197 protein) was more severe. The reporter was wondering if there was a relationship between the two shots (if it was an ingredient in the 2 vaccines or if it was just a lot number problem). Past vaccines given for immunization also included influenza vaccine in 2016 at work and hepatitis B vaccine series on unspecified dates. The reporter stated that the patient''s symptoms had a gradual onset. The patient''s left upper arm started to become red and swollen. The redness spread with pain. The area was outlined. The patient presented on 28Sep2017 with pain, swelling and redness for 3 days. Cellulitis was diagnosed and ibuprofen and warm compresses were recommended. The patient went to the see the on call doctor on 03Oct2017 and she was sent to the emergency room (ER). The patient was admitted to hospital on 03Oct2017 and treated with two doses of vancomycin and ROCEPHIN. The patient was sent home on FLAGYL after an unspecified number of days on an unspecified date in Oct2017. The symptoms were initially worsened, but the reporter was not able to talk to the patient since the ER visit, so the final outcome of event was unknown. The event was considered serious as medically significant event and per initial hospitalization. The reporter stated that the doctor and the patient felt that redness, swelling, pain, and cellulitis were related to pneumococcal 13-val conj vac (dipht crm197 protein), while the reporter did not have a personal opinion on it. Sender''s Comments: Based on the information currently provided, the vaccination with PREVNAR 13 may play a contributory role in triggering the occurrence of cellulitis at left upper arm (vaccination site) considering the close time association. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.


VAERS ID: 719965 (history)  
Form: Version 2.0  
Age: 0.5  
Gender: Male  
Location: South Carolina  
Vaccinated:2017-03-03
Onset:2017-03-07
   Days after vaccination:4
Submitted: 0000-00-00
Entered: 2017-10-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAPIPVHIB: DTAP + IPV + HIB (PENTACEL) / SANOFI PASTEUR C5291AA / 3 LL / IM
FLU4: INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) / SANOFI PASTEUR UT5640LA / UNK RL / IM
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. M031574 / 2 RL / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH Q04603 / 3 LL / IM

Administered by: Private       Purchased by: 0
Symptoms: Electroencephalogram abnormal, Epilepsy, Partial seizures, Seizure
SMQs:, Systemic lupus erythematosus (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Generalised convulsive seizures following immunisation (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 8 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Poly vi sol
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: EEG at the Hospital. Was misdiagnosed for reflux however later confirmed seizures.
CDC Split Type:

Write-up: The pediatrician suggested a flu shot and dtap be given at the same time/same day one after the other. Days after, my baby started having seizures for the first time and has been diagnosed with epilepsy since and is still having seizures bith partial and IS. I believe both shots given on the same day cause my baby''s seizures. I''m upset that the pediatrician even suggested it. My baby was a preemie born at 25 weeks which may have put him at risk of complications with the two given at the same time.


Result pages: prev   64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102   next

New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=83&PERPAGE=20&ESORT=ENTRY-DATE&REVERSESORT=ON&VAX[]=PNC13


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166